IDH1 Gene Sequence Analysis

Definition

IDH1 gene mutations are seen in 6 to 10% of AML patients and in more than 70% of low-grade gliomas. The mutant IDH1 enzyme produces the oncometabolite 2-hydroxyglutarate, leading to DNA/histone hypermethylation and a block in myeloid differentiation.

Gene/region examined

IDH1 exon 4

Method

DNA analysis

Accepted sample types

Bone marrow (EDTA), FFPE

Description

AML prognosis.

Inheritance

This is somatic, a mutation acquired in tumor tissue in both AML and glioma.

Related Tests